UBS raised the firm’s price target on HCA Healthcare (HCA) to $598 from $525 and keeps a Buy rating on the shares.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- HCA Healthcare price target raised to $540 from $500 at Oppenheimer
- HCA Healthcare price target raised to $588 from $525 at Cantor Fitzgerald
- HCA Healthcare price target raised to $550 from $500 at KeyBanc
- HCA Healthcare price target raised to $551 from $494 at Barclays
- HCA Healthcare Earnings Call: Growth Amid Policy Strain